|Articles|July 22, 2016
EMA Seeks to Revise Guidance on First-In-Human Trials
July 22, 2016
Advertisement
The European Medicines Agency (EMA) is proposing changes to the current guidelines on first-in-human clinical trials to improve risk-based strategies. This proposal was made with cooperation from the European Commission and the Member States of the European Union (EU).
Read the full release
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote
2
BMS vs. Moderna vs. Pfizer: The RNA Platform Race
3
Asembia's AXS26 Summit: Q&A with Kim Plesnarski
4
Asembia ASX26: Strategies for Building Relationships with Pharma Manufacturers
5